IFNG and cancer: It has been shown in melanoma that the interferon-gamma-JAK1/JAK2-STAT1/STAT2/STAT3-IRF1 signaling cassettes primarily regulates PD-L1 expression on the cancer cell, through IRF1 binding to its promoter.